PeptideDB

CH5015765

CAS: 959766-47-3 F: C16H13ClN4OS W: 344.82

CH5015765 is an orally available Hsp90 inhibitor bound to the N-terminal ATP bindingsite. CH5015765 plays an important r
Sales Email：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity CH5015765 is an orally available Hsp90 inhibitor bound to the N-terminal ATP bindingsite. CH5015765 plays an important role in cancer research[1].
CAS 959766-47-3
Formula C16H13ClN4OS
Molar Mass 344.82
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Reference [1]. Atsushi Suda, et al. Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1136-41.

14-Anhydrodigitoxigenin

4-Dibenzofurancarboxylic acid

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.